BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10759821)

  • 1. A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier.
    Romagosa R; Saap L; Givens M; Salvarrey A; He JL; Hsia SL; Taylor JR
    Dermatol Surg; 2000 Apr; 26(4):338-40. PubMed ID: 10759821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
    Gross K; Kircik L; Kricorian G
    Dermatol Surg; 2007 Apr; 33(4):433-9; discussion 440. PubMed ID: 17430377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
    Orenberg EK; Miller BH; Greenway HT; Koperski JA; Lowe N; Rosen T; Brown DM; Inui M; Korey AG; Luck EE
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):723-8. PubMed ID: 1430394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
    Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
    Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorouracil paste treatment of thin basal cell carcinomas.
    Epstein E
    Arch Dermatol; 1985 Feb; 121(2):207-13. PubMed ID: 3977335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream.
    Beutner KR; Geisse JK; Helman D; Fox TL; Ginkel A; Owens ML
    J Am Acad Dermatol; 1999 Dec; 41(6):1002-7. PubMed ID: 10570388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
    Mansell PW; Litwin MS; Ichinose H; Krementz ET
    Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
    Litwin MS; Krementz ET
    Panminerva Med; 1974 Mar; 16(3):84-5. PubMed ID: 4449647
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
    Miller BH; Shavin JS; Cognetta A; Taylor RJ; Salasche S; Korey A; Orenberg EK
    J Am Acad Dermatol; 1997 Jan; 36(1):72-7. PubMed ID: 8996264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
    Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
    Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytotoxic effect of topical 5-fluorouracil.
    Dillaha CJ; Jansen GT; Honeycutt WM; Bradford AC
    Arch Dermatol; 1983 Sep; 119(9):774-83. PubMed ID: 6614965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma.
    Wenande E; Hendel K; Mogensen M; Bagger C; MÃ¥rtensson NL; Persson DP; Lerche CM; Husted S; Janfelt C; Togsverd-Bo K; Anderson RR; Haedersdal M
    Lasers Surg Med; 2021 Jan; 53(1):119-128. PubMed ID: 32960987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
    Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
    J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
    Berman B; Sullivan T; De Araujo T; Nadji M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of local administration of 5% 5-fluorouracil in the therapy of senile keratoses and basocellular carcinoma].
    Poljacki M; Stojanović S; Svilar V
    Med Pregl; 1989; 42(3-4):149-51. PubMed ID: 2636692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical use of 5-fluorouracil cream for skin cancer.
    Ryan RF; Litwin MS; Reed RJ
    Mod Trends Surg; 1971; 3():284-96. PubMed ID: 5120468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.